Contractile effects by intracellular angiotensin II via receptors with a distinct pharmacological profile in rat aorta

British Journal of Pharmacology

Volumn 126, Issue 5, 1999, Pages 1133-1138

  Brailoiu, Eugen ^a,c   Filipeanu, Catalin M ^a,d   Tica, Andrei ^b   Toma, Catalin P ^a   De Zeeuw, Dick ^d   Nelemans, S Adriaan ^d  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^c East Tennessee State University   (United States)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Angiotensin I; Intracellular angiotensin II; Liposomes; Saralasin; Vascular smooth muscle

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN I; CALCIUM ION; CANDESARTAN; HEPARIN; INOSITOL 1,4,5 TRISPHOSPHATE; PHENYLEPHRINE; RECEPTOR; SARALASIN;

ANIMAL TISSUE; AORTA; AORTA CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING SITE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; CALCIUM; MALE; MUSCLE, SMOOTH, VASCULAR; PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; SARALASIN; VASOCONSTRICTION;

EID: 0033012299     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702421     Document Type: Article

References (30)

1. ALEXANDER, R.W., BROCK, T.A., GIMBRONE JR, M.A. & RITTENHOUSE, S.E. (1985). Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle. Hypertension, 7, 447-451.
2. ANDERSON, K.M., MURAHASHI, T., DOSTAL, T.E. & PEACH, M.J. (1993). Morphological and biochemical analysis of angiotensin II internalization in cultured rat aortic smooth muscle cells. Am. J. Physiol., 46, C179-C188.
3. BANGHAM, A.D., STANDISH, M.M. & WATKINS, J.C. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol., 13, 238-252.
4. BOULAY, G., CHRETIEN, L., RICHARD, D.L. & GUILLEMETTE, G. (1994). Short-term desensitization of the angiotensin II receptor of bovine adrenal glomerulosa cells corresponds to a shift from a high to a low affinity state. Endocrinology, 135, 2130-2136.
5. BRAILOIU, E., BALTATU, O., COSTULEANU, M., SLATINEANU, S., FILIPEANU, C.M. & BRANISTEANU, D.D. (1995). Effects of α-trinositol administered extra-and intracellularly (using liposomes) on rat aorta rings. Eur. J. Pharmacol., 281, 209-212.
6. BRAILOIU, E., SERBAN, D.N., POPESCU, L.M., FILIPEANU, C.M., SLATINEANU, S. & BRANISTEANU, D.D. (1993). Effects of liposome-entrapped Ins(1,4,5)P3 and Ins(1,3,4,5)P4 in the isolated rat aorta. Eur. J. Pharmacol., 250, 493-495.
7. BRAILOIU, E., TODIRAS, M., MARGINEANU, A., COSTULEANU, M., BRAILOIU, C., FILIPEANU, C.M., COSTULEANU, A., RUSU, V. & PETRESCU, G. (1997). TLC characterisation of liposomes containing angiotensinogen, angiotensin I, angiotensin II and saralasin. Biomed. Chromatogr., 11, 160-163.
8. BRAILOIU, E., & VAN DER KLOOT, W. (1996). Bromoacetylcholine and acetylcholinesterase introduced via liposomes into motor nerve endings block increases in quantal size. Pfluegers Arch./ Eur. J. Physiol., 432, 413-418.
9. COSTULEANU, M., BRAILOIU, E., FILIPEANU, C.M., BALTATU, O., SLATINEANU, S., NECHIFOR, M. & BRANISTEANU, D.D. (1995). Effects of platelet-activating factor-entrapped liposomes upon rat trachea. Eur. J. Pharmacol., 281, 89-93.
10. CROMMELIN, D.J.A., DAEMEN, T., SCHERPHOF, G.L., VINGER-HOEDS, M.H., HEEREMANS, J.L.M., KLUFT, C. & STORM, G. (1997). Liposomes: vehicles for the targeted and controlled delivery of peptides and proteins. J. Control. Rel., 46, 165-175.
11. DANTHULURI, N.R. & DETH, R.C. (1986). Acute desensitization to angiotensin II: evidence for a requirement of agonist induced diacylglycerol production during tonic contraction of rat aorta. Eur. J. Pharmacol., 126, 135-139.
12. DE MELLO, W.C. (1994). Is an intracellular renin-angiotensin system involved in control of cell communication in heart? J. Cardiovasc. Pharmacol., 23, 640-646.
13. ERDMANN, B., FUXE, K. & GANTEN, D. (1996). Subcellular localization of angiotensin II immunoreactivity in the rat cerebellar cortex. Hypertension, 28, 818-824.
14. FERRARIO, C.M., CHAPPELL, M.C., TALLANT, E.A., BROSNIHAN, K.B. & DIZ, D.I. (1997). Counterregulatory actions of angiotensin-(1-7). Hypertension, 30, 535-541.
15. FILIPEANU, C.M., BRAILOIU, E., PETRESCU, G. & NELEMANS, S.A. (1998a). Extracellular and intracellular arachidonic acid-induced contractions in rat aorta. Eur. J. Pharmacol., 349, 67-73.
16. FILIPEANU, C.M., HENNING, R.H., DE ZEEUW, D. & NELEMANS, S.A. (1998b). Functional evidence for a role of intracellular angiotensin II in A7r5 cells. Br. J. Pharmacol., 123, 141P.
17. GAVRAS, H.P. & SALERNO, C.M. (1996). The angiotensin II type 1 receptor blocker losartan in clinical practice: review. Clin. Ther., 18, 1058-1067.
18. GRIENDLING, K.K., RITTENHOUSE, S.E., BROCK, T.A., EKSTEIN, L.S., GIMBRONE JR., M.A. & ALEXANDER, R.W. (1986). Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J. Biol. Chem., 261, 5901-5906.
19. GRIENDLING, K.K., USHIO-FUKAI, M., LASSEGUE, B. & ALEXANDER, R.W. (1997). Angiotensin II signalling in vascular smooth muscle. New concepts. Hypertension, 29, 366-373.
20. HALLER, H., LINDSCHAU, C., ERDMANN, B., QUASS, P. & LUFT, F.C. (1996). Effect of intracellular angiotensin II in vascular smooth muscle cells. Circ. Res., 79, 765-772.
21. KIRON, M.A. & SOFFER, R.L. (1989). Purification and properties of a soluble angiotensin II binding protein from rabbit liver. J. Biol. Chem., 264, 4138-4142.
22. LE NOBLE, F.A.C., SCHREURS, N.H.J.S., VAN STRAATEN, H.W.M., SLAAF, D.W., SMITS, J.F.M., ROGG, H. & STRUIJKER-BOUDIER, H.A.J. (1993). Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am. J. Physiol., 264, R460-R465.
23. LI, X., SHAMS, M., ZHU, J., KHALIG, A., WILKES, M., WHITTLE, M., BARNES, N. & AHMED, A. (1998). Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. J. Clin. Invest., 101, 442-454.
24. MANOLOPOULOS, V.G., PIPILI-SYNETOS, E., DEN HERTOG, A. & NELEMANS, A. (1991). Inositol phosphates formed in rat aorta after α1-adrenoceptor stimulation are inhibited by forskolin. Eur. J. Pharmacol., 207, 29-36.
25. MURPHY, T.J., ALEXANDER, R.W., GRIENDLING, K.K., RUNGE, M.S. & BERNSTEIN, K.E. (1991). Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature, 351, 233-236.
26. SKEGGS, L.T., LENTZ, K.E., SHUMAWAY, N.P. & WOODS, K.R. (1956). The amino acid sequence of hypertensin. J. Exp. Med., 104, 193-197.
27. SMITH, J.B. (1986). Angiotensin receptor signalling in cultured vascular smooth muscle cells. Am. J. Physiol., 250, F759-F769.
28. TIMMERMANS, P.B.M.W.M., WONG, P.C., CHIU, A.T., HERBILIN, W.F., BENFIELD, P., CARINI, D.J., LEE, R.J., WEXLER, R.R., SAYE, J.A.M. & SMITH, R.D. (1993). Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev., 45, 205-251.
29. VAN KATS, J.P., DE LANNOY, L.M., DANSER, J.A.H., VAN MEEGEN, J.R., VERDOUW, P.D. & SCHALEKAMP, M.D. (1997). Angiotensin II type 1 (ATI) receptor mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension, 30, 42-49.
30. YAMAMOTO, D., SHIOTA, N., TAKAI, S., ISHIDA, T., OKUNISHI, H. & MIYAZAKI, M. (1998). Three-dimensional molecular modeling explains why catalytic function for angiotensin-I is different between human and rat chymases. Biochem. Biophys. Res. Commun., 242, 158-163.